Scientists probe the mystery of dense breasts and cancer
NCT ID NCT00475761
First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 9 times
Summary
This study looked at why some women have dense breasts on mammograms and why that increases their risk of breast cancer. Researchers collected tissue samples, medical records, and health updates from 466 women aged 40-65 who were having a breast biopsy. The goal was to understand what makes breast tissue dense and how it might lead to cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
466 people
The number who actually took part.
- Started
-
May 2007
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Primary clinical- patients referred to diagnostic breast biopsy due to an abnormal breast imaging exam.
- Ages
-
40 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA: Inclusion criteria for participation in the study are women, ages 40-65 years of age, who are undergoing a radiologically-guided biopsy (stereotactic- ultrasound-guided). We will NOT exclude subjects for current or past use of exogenous hormones; prior hysterectomy or salpingoophorectomy or presentation with a breast mass. Although most biopsies are prompted by a radiologic finding (typically abnormal calcifications or masses), some biopsies are performed for symptoms that are unassociated with a radiologic finding, such as nipple discharge, palpable mass, discomfort, etc. Elevated density per se is not a biopsy indication. ALL women referred for radiologically guided biopsy, irrespective of the indication, will be considered eligible for the pilot study. EXCLUSION CRITERIA: We will EXCLUDE women who have a prior history of breast cancer, have had an EXCISIONAL breast biopsy within one year, women who have implants in place, women taking tamoxifen or raloxifene for chemoprevention and women who have received non-surgical treatments for cancers of other organs.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast neoplasms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Vermont
Burlington, Vermont, 05405, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can dancing ease the exhaustion of breast cancer treatment?
- AI reads tumor slides to match cancer patients with trials
- Lung imaging could reveal the best anesthetic dose for breast surgery
- Can a Dual-Target drug crack resistant gynecologic and breast cancers?
- AI turns routine chest scans into breast cancer detector
- One shot of radiation: can a single dose replace weeks of breast cancer treatment?